This presentation explains the role of and rationale for opioid rotation in pain treatment plans involving opioid analgesics.
Tag: opioid risk
In the past several years, opioid misuse and abuse has become an increasing problem in our society. Recently, the death of music icon, Prince, was attributed to an accidental overdose of Fentanyl, a powerful synthetic opiate used to treat chronic pain. This problem is not limited to high-profile celebrities –– according to the Centers for… Read more »
An interview with Mary Lynn McPherson, PharmD, MA, BCPS, CPE, about the pharmacist’s role in the management of a patient’s chronic pain.
One of the four definitions that the Merriam-Webster dictionary offers for tampering is “to render something harmful or dangerous by altering its structure or composition.” There is nothing in the definition about intention, such as intent to break the law, intent “to get high,” or other aberrant drug-related behaviors; just the fact that something that changes structure… Read more »
An interview with Kevin L. Zacharoff, MD and licensed, board-certified anesthesiologist about ER/LA opioid REMS and REMS education.
An interview with Marc O. Martel, PhD about the association between negative affect and prescription opioid misuse in patients with chronic pain.
Many clinicians may have reluctance to prescribe opioids for patients in pain outside of the most controlled of situations (i.e., when the patient is a hospital inpatient). This phenomenon is fairly well accepted by clinicians and patients, and is often the result of some combination of a variety of factors: – Clinicians who are not experts… Read more »
When we last covered the topic of the FDA’s intended plans for curbing opioid risk, we felt confident that one thing was for sure – education would likely be a key ingredient of the ultimate implemented solution. As it turns out, our assumption was correct. As we mentioned in our opioid REMS update 2012, on Tuesday, April… Read more »
Globally, it was estimated that a total of 365 million prescriptions were written for opioids in 2005, with 235 million of those written in the United States. A significant proportion of them were for the treatment of chronic pain. In the USA, 20% of prescriptions for opioid therapy were for over 30 days’ duration1. Today,… Read more »
An interview with Jeffrey Fudin, BS, PharmD, FCCP about Professionals for Rational Opioid Monitoring & PharmacoTherapy (PROMPT).